Learn More
Bone marrow transplantation or ponatinib treatment are currently recommended strategies for management of patients with chronic myeloid leukemia (CML) harboring the T315I mutation and compound or(More)
Sir, Monitoring BCR-ABL1 kinase activity by assaying CRKL phosphorylation (P-CRKL), a technique first introduced by Gorre et al. [1], has proven to be a reliable method for the assessment of the(More)
  • 1